全文获取类型
收费全文 | 14807篇 |
免费 | 968篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 71篇 |
儿科学 | 506篇 |
妇产科学 | 407篇 |
基础医学 | 1897篇 |
口腔科学 | 94篇 |
临床医学 | 2421篇 |
内科学 | 2502篇 |
皮肤病学 | 446篇 |
神经病学 | 1222篇 |
特种医学 | 417篇 |
外科学 | 1447篇 |
综合类 | 154篇 |
一般理论 | 8篇 |
预防医学 | 1953篇 |
眼科学 | 122篇 |
药学 | 904篇 |
中国医学 | 9篇 |
肿瘤学 | 1213篇 |
出版年
2023年 | 75篇 |
2022年 | 138篇 |
2021年 | 244篇 |
2020年 | 154篇 |
2019年 | 239篇 |
2018年 | 283篇 |
2017年 | 274篇 |
2016年 | 246篇 |
2015年 | 283篇 |
2014年 | 443篇 |
2013年 | 680篇 |
2012年 | 973篇 |
2011年 | 1037篇 |
2010年 | 600篇 |
2009年 | 539篇 |
2008年 | 904篇 |
2007年 | 1025篇 |
2006年 | 959篇 |
2005年 | 1039篇 |
2004年 | 1032篇 |
2003年 | 965篇 |
2002年 | 878篇 |
2001年 | 177篇 |
2000年 | 148篇 |
1999年 | 174篇 |
1998年 | 173篇 |
1997年 | 150篇 |
1996年 | 125篇 |
1995年 | 107篇 |
1994年 | 100篇 |
1993年 | 119篇 |
1992年 | 111篇 |
1991年 | 118篇 |
1990年 | 106篇 |
1989年 | 93篇 |
1988年 | 89篇 |
1987年 | 75篇 |
1986年 | 92篇 |
1985年 | 73篇 |
1984年 | 77篇 |
1983年 | 64篇 |
1982年 | 66篇 |
1981年 | 51篇 |
1980年 | 47篇 |
1979年 | 41篇 |
1978年 | 25篇 |
1977年 | 39篇 |
1976年 | 27篇 |
1975年 | 34篇 |
1974年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
31.
High-Temperature Short-Time Heat Inactivation of HIV and Other Viruses in Human Blood Plasma 总被引:4,自引:0,他引:4
Stanley E. Charm Steven Landau Bolanle Williams Bernard Horowitz Alfred M. Prince and Donna Pascual 《Vox sanguinis》1992,62(1):12-20
An ultra-short-time heating system was used to process blood plasma spiked with various viruses (HIV, vesicular stomatitis virus, encephalomyocarditis virus). Virus reduction and recovery of plasma proteins were measured at various temperatures from 65 to 85 degrees C. Processing at 77 degrees C and 0.006 s resulted in a high level of virus kill, including greater than or equal to 4.4 log10 HIV, while maintaining protein structure and activity essentially intact. 相似文献
32.
M. S. Beer J. A. Stanton Y. Bevan A. Heald A. J. Reeve L. J. Street V. G. Matassa R. J. Hargreaves D. N. Middlemiss 《British journal of pharmacology》1993,110(3):1196-1200
1. The 5-hydroxytryptamine (5-HT) receptor binding selectivity profile of a novel, potent 5-HT1D receptor agonist, L-694,247 (2-[5-[3-(4-methylsulphonylamino)benzyl-1,2,4-oxadiazol-5-yl ]- 1H-indole-3-yl]ethylamine) was assessed and compared with that of the 5-HT1-like receptor agonist, sumatriptan. 2. L-694,247 had an affinity (pIC50) of 10.03 at the 5-HT1D binding site and 9.08 at the 5-HT1B binding site (sumatriptan: pIC50 values 8.22 and 5.94 respectively). L-694,247 retained good selectivity with respect to the 5-HT1A binding site (pIC50 = 8.64), the 5-HT1C binding site (6.42), the 5-HT2 binding site (6.50) and the 5-HT1E binding site (5.66). The pIC50 values for sumatriptan at these radioligand binding sites were 6.14, 5.0, < 5.0 and 5.64 respectively. Both L-694,247 and sumatriptan were essentially inactive at the 5-HT3 recognition site. 3. L-694,247, like sumatriptan, displayed a similar efficacy to 5-HT in inhibiting forskolin-stimulated adenylyl cyclase in guinea-pig substantia nigra although L-694,247 (pEC50 = 9.1) was more potent than sumatriptan (6.2) in this 5-HT1D receptor mediated functional response. L-694,247 (pEC50 = 9.4) was also more potent than sumatriptan (6.5) in a second 5-HT1D receptor mediated functional response, the inhibition of K(+)-evoked [3H]-5-HT release from guinea-pig frontal cortex slices.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
33.
34.
Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. 总被引:5,自引:0,他引:5
Ambros J Beer Roland Haubner Michael Goebel Stephan Luderschmidt Mary E Spilker Hans-Jürgen Wester Wolfgang A Weber Markus Schwaiger 《Journal of nuclear medicine》2005,46(8):1333-1341
(18)F-Galacto-RGD has been developed for PET of alpha(v)beta(3) integrin expression, a receptor involved in, for example, angiogenesis and metastasis. Our aim was to study the kinetics and biodistribution of (18)F-Galacto-RGD in cancer patients. METHODS: Nineteen patients with metastases of malignant melanoma (n = 7), sarcomas (n = 10), or osseous metastases (n = 2) were examined. After injection of 133-200 MBq (18)F-Galacto-RGD, 3 consecutive emission scans from the pelvis to the thorax or dynamic emission scans of the tumor over 60 min, followed by 1 static emission scan of the body, were acquired. Time-activity curves and standardized uptake values (SUVs) were derived by image region-of-interest analysis with image-based arterial input functions. Compartmental modeling was used to derive the distribution volume for muscle tissue and tumors. RESULTS: (18)F-Galacto-RGD showed rapid blood clearance and primarily renal excretion. SUVs in tumors ranged from 1.2 to 9.0. Tumor-to-blood and tumor-to-muscle ratios increased over time, with peak ratios of 3.1 +/- 2.0 and 7.7 +/- 4.3, respectively, at 72 min. The tumor kinetics were consistent with a 2-tissue compartment model with reversible specific binding. Distribution volume values were, on average, 4 times higher for tumor tissue (1.5 +/- 0.8) than those for muscle tissue (0.4 +/- 0.1). The data suggest that there was only minimal free and bound (specific or nonspecific) tracer in muscle tissue. CONCLUSION: (18)F-Galacto-RGD demonstrates a highly favorable biodistribution in humans with specific receptor binding. Most important, this study shows that (18)F-Galacto-RGD allows visualization of alpha(v)beta(3) expression in tumors with high contrast. Consequently, this tracer offers a new strategy for noninvasive monitoring of molecular processes and may supply helpful information for planning and controlling of therapeutic approaches targeting the alpha(v)beta(3) integrin. 相似文献
35.
Donna Carlton 《Nephrology nursing journal》2005,32(6):688-690
In summary, the access coordinator is at the center of our access program at UAB. The coordinators can make decisions based on the calls we receive from the nursing staff and reports obtained from procedures. The ability to relay information to the entire team rather than simply data entry staff, makes us a central focal area for our access team. This type of model is working to help us achieve better patient outcomes. We provide many services but the most important is follow-up. As a result, we are able to achieve optimal outcomes for our patients. 相似文献
36.
37.
Brian J Forbes Gil Binenbaum Jane C Edmond Nicole DeLarato Donna M McDonald-McGinn Elaine H Zackai 《Journal of AAPOS》2007,11(2):179-182
PURPOSE: To identify the ocular features of the chromosome 22q11.2 deletion syndrome and to provide ophthalmologic examination recommendations for affected patients. METHODS: Ocular abnormalities were evaluated prospectively in patients with 22q11.2 deletion at the Children's Hospital of Philadelphia between 1997 and 1999. RESULTS: Ninety patients with confirmed 22q11.2 deletion were examined. Posterior embryotoxon was found in 49%, tortuous retinal vessels in 34%, eyelid hooding in 20%, strabismus in 18%, ptosis in 4%, amblyopia in 4%, and tilted optic nerves in 1%. CONCLUSIONS: The high incidence of ocular conditions that can potentially affect visual development suggest that children with 22q11.2 deletion should undergo a comprehensive eye examination upon diagnosis of the condition with follow-up as indicated by the findings in each case. In addition, knowledge of the ocular findings, in conjunction with certain cardiac, otolaryngologic, immunologic, and other systemic findings, may alert physicians to the possibility of a chromosome 22q11.2 deletion. 相似文献
38.
Hermann J Girschick Etienne Mornet Meinrad Beer Monika Warmuth-Metz Peter Schneider 《BMC pediatrics》2007,7(1):3
Background
Hypophosphatasia (HP) is characterized by a genetic defect in the tissue-nonspecific alkaline phosphatase (TNSALP) gene and predominantly an autosomal recessive trait. HP patients suffer from reduced bone mineralization. Biochemically, elevated concentrations of substrates of TNSALP, including pyridoxal-5'-phosphate and inorganic pyrophosphate occur in serum, tissues and urine. The latter has been associated with chronic inflammation and hyperprostaglandinism. 相似文献39.
Donna P. Smith 《Children's Health Care》1986,14(3):187-188
Humor has become a popular topic in health care recently. One of the suggested benefits is to help control pain. Although no scientific research to date has validated this effect, there is some theoretical and empirical support for the use of humor especially with children. Methods to implement the uses of humor in a clinical setting are suggested inappropriate uses of humor are also discussed. The need for scientific research is stressed. 相似文献
40.